Curriculum Vitae
PERSONAL INFORMATION Janet Mifsud
WORK EXPERIENCE
July 2011- Present Professor University of Malta (Malta) Academic Co-ordinator for the undergraduate curriculum for pharmacology and pharmacokinetics modules and study units offered at the University of Malta for Faculty of Medicine and Surgery; Faculty of Health Sciences; Faculty of Science; Faculty of Education; Faculty of Dental Surgery at the University of Malta. Co-ordinator and member of board of studies MSc (Pharmacology/Clinical Pharmacology), University of Malta. Co-ordinator, Pharmacotoxicology Course, University of Malta. Supervision, under and postgraduate students at the University of Malta. Supervision of students undertaking Masters and Doctoral projects in collaboration with the Queens University of Belfast, Kings College London
Administrative Liaison with technical staff for the orders of chemical and laboratory equipment for students and research and updates of departmental website Daily liaison with administrative staff related to timetables of lectures and examinations, issuing of results, and tasks related to the running of the department Liaison with administrative staff at Medical school, Registrars office and APQRU for administration of courses, running of examinations and curricular development.
Research Research in the pharmacokinetic, pharmacodynamic modeling and pharmacogenetics in the pharmacological treatment of epilepsy. Research in abuse of prescribed and OTC medication Preparation of grant proposals for from EU and other funding sources.
April 2018- Present Professor University of Malta (Malta) Co-ordinator for the undergraduate curriculum for pharmacology and pharmacokinetics modules and study units offered at the University of Malta for Faculty of Medicine and Surgery; Faculty of Health Sciences; Faculty of Science; Faculty of Education; Faculty of Dental Surgery at the University of Malta. Co-ordinator and member of board of studies MSc (Pharmacology/Clinical Pharmacology), University of Malta. Co-ordinator, Pharmacotoxicology Course, University of Malta. Supervision, under and postgraduate students at the University of Malta. Supervision of students undertaking Masters and Doctoral projects in collaboration with the Queens University of Belfast, Kings College London
Administrative Liaison with technical staff for the orders of chemical and laboratory equipment for students and research and updates of departmental website Daily liaison with administrative staff related to timetables of lectures and examinations, issuing of
22/12/2020 European Medicine Agency Page 1/20 results, and tasks related to the running of the department Liaison with administrative staff at Medical school, Registrars office and APQRU for administration of courses, running of examinations and curricular development.
Research Research in the pharmacokinetic, pharmacodynamic modeling and pharmacogenetics in the pharmacological treatment of epilepsy. Research in abuse of prescribed and OTC medication Preparation of grant proposals for from EU and other funding sources.
January 1990-April 2018 Lecturer University of Malta (Malta) Lecturer for the undergraduate curriculum for pharmacology and pharmacokinetics modules and study units offered at the University of Malta for Faculty of Medicine and Surgery; Faculty of Health Sciences; Faculty of Science; Faculty of Education; Faculty of Dental Surgery at the University of Malta.
May 1985-December 1989 Clinical Pharmacist Department of Health (Malta) o member of the Drugs and Therapeutics Committee and Medicinal Devices Committee of the Government Pharmaceutical Service, which provides pharmaceutical provisions to all the state health service in Malta. o Interactions with several other health care professionals, consultants, nursing staff etc. and hospital administrators
January 2010-May 2017 COST national contact point Malta Council for Science and Technology (Malta) skills and competencies have let to my appointment as Maltas CNC and CSO for COST, the intergovernmental framework for European Co-operation in the field of Scientific and Technical Research. My activities in this area have led to Maltas participation to 150 novel COST actions (in four years).
January 2004-April 2010 Commissioner, National Commission for the Promotion of Equality Ministry for Social Policy (Malta) o I was responsible for the implementation of the Equality Act, Chapter 456; Legal notices 85/2007 and 18/2007 of the Laws of Malta o I chaired over 60 Commission meetings and 50 complaints meetings at NPCE over a span of 6 years o I was also responsible for the management of large ESF and EDRF budget for NCPE projects which amount to over 10 million euros. o I liaised and co-ordinated policies and their implementation on regular basis with policy makers, stakeholders and government officials and ministers
June 2001-June 2009 Member, Public Service Commission Government of Malta (Malta) is a constitutional body, which oversees all appointments and disciplinary procedures in the Malta Public Service.
EDUCATION AND TRAINING
June 1990-December 1995 Doctor of Philosophy Queen's University of Belfast (United Kingdom)
22/12/2020 European Medicine Agency Page 2/20 Pharmacokinetic and Pharmacodynamic of chiral antiepileptic drugs - in vivo models - chromatographic techniques - PK modelling - population pharmacokinetics
October 2007-October 2013 Bachelor of Theology (Hons) University of Malta (Malta) theology, philosophy, ethics, metaphysics, moral theology,
October 1983-June 1986 Bachelor of Pharmacy(Hons) University of Malta (Malta) Pharmacokinetics of Cardiovascular drugs
December 2012-December 2012 training Kings College London (United Kingdom) Introduction to Data Analysis using a Population Approach, NONMEM,
July 2006-July 2006 training Simcyp (United Kingdom) SIMCYP Pharmacokinetic software training course
June 2004-June 2004 training ADAPT II Pharmacokinetic systems analysis software training course, Germany (Germany) population pharmacokinetics modelling using ADAPT
June 2007-September 2007 Fulbright Scholar award, University of Minnesota (United States) population pharmacokinetics of antiepileptic drugs
July 1999-July 1999 DAAD award Bethel Epilepsy Centre (Germany) TDM of antiepileptic drugs
ADDITIONAL INFORMATION
Expertise Although formally I am an Professor at the University of Malta, over the last few years, I have gained a great deal of academic, research and managerial experience and competencies, both on a national as well as a European and international level in various spheres. Several of these have included key decision making positions of very important societal relevance, requiring the management of large budgets and leadership skills. My commitments have been wide reaching and extremely varied, cutting across a range of scientific, research, academic and administrative disciplines, allowing me to develop a unique assortment of skills and experiences. Some of these include: - Former Clinical Pharmacist at the major teaching hospital in Malta, o member of the Drugs and Therapeutics Committee and Medicinal Devices Committee of the Government Pharmaceutical Service, which provides pharmaceutical provisions to all the state health service in Malta. o Interactions with several other health care professionals, consultants, nursing staff etc. and hospital administrators - Obtained several scholarships and awards which led to research experience with top international research communities in Ireland, UK, Italy, Germany and US (Fulbright scholar)
22/12/2020 European Medicine Agency Page 3/20 - Undertaken and supervised key interdisciplinary research on various aspects of the incidence, pharmacokinetics and pharmacogenomics and treatment of epilepsy in specific populations and the newer antiepileptic drugs, especially within a small population setting such as Malta, in conjunction with the Department of Paediatrics and Department of Medicine at Mater Dei Hospital and the University of Malta, the International League Against Epilepsy (ILAE) and International Bureau of Epilepsy (IBE). - Outreach and advocacy work especially in the epilepsy sphere, since I have always believed that research should not remain blue sky research. o In 1996, I founded the Caritas Malta Epilepsy Association. o In 2007, I set up the Pharmacology Society of Malta. - My international status is now well acknowledged and I have been invited to sit on several International Committees such as: o Scientific Committee of the Mediterranean Epilepsy Society, o International League against Epilepsy, o European Federation of Pharmaceutical Sciences o UNESCO Forum of Women of the Mediterranean. o EUCARE EU concerted Action in Epilepsy o Secretary General, European Epilepsy Academy o Vice-President (Europe) International Bureau for Epilepsy o Member, IBE/ILAE Joint Task Force, Epilepsy Research and Advocacy. o Former expert of the EU European Medicines Agency on the Pharmacogenetics group in European Medicines Agency in London o Invited expert evaluator for EU Framework Research programmes.
- During my term as member of the Drugs and Therapeutics Committee and Medicinal Devices Committee of the Government Pharmaceutical Service, which provides pharmaceutical provisions to all the state health service in Malta, I obtained technical skills and knowledge about the quality, safety and efficacy of pharmaceutical products and devices. - Through my doctoral research, I obtained skills in chromatographic analysis (HPLC; GC/MS) specifically of drugs in biological fluids, in vivo animal epilepsy models and pharmacokinetic analysis using sparse data analysis software. - I also have obtained competencies with respect to EU regulatory requirements for quality control criteria for medicines and the importance of the predicative value of pharmacokinetic especially with respect to stereoisomeric pharmacovigilance and pharmacotoxicology in hospital formularies and the regulatory implications in national health services. - I have also acted as external adviser for the development of pharmacology computer learning packages developed by the UK PharmaCalogy network and contributed to the content of the Cal packages developed by the European Pharmacology Network Epharnet, co-ordinated by Dr Ian Hughes from University of Leeds. - I introduced post graduate taught degrees in pharmacology at the University of Malta . I wasalso a member of the GALENOS network, coordinated by the University of Saarbrucken Germany, which promotes a postgraduate degree in pharmaceutical sciences across 34 universities. - I have acted as a consultant on EU affairs to several key institutions in Malta, including local pharmaceutical manufacturing industry on the registration procedures for their medicinal products for animal and human use in line with EU regulatory bodies. - Participation in European Medicines Agency, Pharmacogenetics Working Party (PGWP) has led to increased relations and collaborations with colleagues in other national and international drug regulatory agencies such as ICH, FDA. - I have also been appointed over 60 times expert evaluator as well as expert reviewer for proposals submitted under various EU funding schemes: FP5, FP6 and FP7. These evaluations included the actions: Marie Curie Excellence Grants and Chairs, Life Sciences Genomics for Health, INCO Specific Support Actions, Ethics Review, Leonardo Projects, Erasmus Mundus, Quality of Life Measures, DG Transport and the Science and Society Young Scientists Contest and as Ethics
22/12/2020 European Medicine Agency Page 4/20 reviewer. o In 2009 I was also selected as evaluator for proposals submitted under the prestigious IMI Innovative Medicines Initiative. o In 2010 I was also appointed the first Maltese evaluator for the European Science Foundation (ESF) under the EUROCORES call.
Publications Peer reviewed publications Braga P, Mifsud J, D'Souza C, Clarke M, Honein A, Tovuudorj A, Pfäfflin M Education and epilepsy: Examples of good practice and cooperation. Report of the IBE Commission on Education. Epilepsy Behav. 2020 Feb;103(Pt A):106653. doi: 10.1016/j.yebeh.2019.106653. Epub 2019 Nov 21. Bakkum MJ, Tichelaar J, Papaioannidou P, Likic R, Sanz Alvarez EJ, Christiaens T, Costa JN, Maiulaitis R, Dima L, Coleman J, Richir MC, van Agtmael MA; Mifsud J Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and its affiliated Network of Teachers in Pharmacotherapy (NOTIP). Harmonizing and improving European education in prescribing: An overview of digital educational resources used in clinical pharmacology and therapeutics. Br J Clin Pharmacol. 2020 Jul 7. doi: 10.1111/bcp.14453. Online ahead of print. Pitkänen A, Henshall DC, Cross JH, Guerrini R, Jozwiak S, Kokaia M, Simonato M, Sisodiya S, Mifsud J.Advancing research toward faster diagnosis, better treatment, and end of stigma in epilepsy. Epilepsia. 2019 Jul;60(7):1281-1292. doi: 10.1111/epi.16091. Epub 2019 Jun 18. Review. Zelano J, Klecki J, Christensen J, Tomson T, Malmgren K; ESBACE consortium Collaborators.The provision of epilepsy care across Europe 2017: A 17-year follow-up survey. Epilepsia Open. 2019 Feb 15;4(1):144-152. doi: 10.1002/epi4.12306. eCollection 2019 Mar. Mifsud, J.; Gavrilovici, C.Title Big Data in Healthcare and the Life Sciences in Ethics and Integrity in Health and Life Sciences Research ed Koporc, Z; 2018, 63-8, Emerald Publishing, London. Mifsud,J.; Brodie,M. Lay epilepsy organizations: The key for research funding? Epilepsy and Behaviour, 2018, 81, 123-124 Mifsud J, Administering epilepsy rescue medication to children: why and why not? Eur J Paed Neurology Invited Editorial. 2018, 22, 1, 6 Mifsud J, Using antiepileptic drugs in children: recent developments and recommendations Journal of the Malta College of Pharmacy Practice, 2017 23:25-30 Brinkman,D.J.; Tichelaar,J.; Mokkink,L.B.; Christiaens,T.; Likic,R.; Maciulaitis,R.; Costa,J.; Sanz,E.J.; Maxwell,S.R.; Richir,M.C.; Mifsud, J.; et, al, Key learning outcomes for clinical pharmacology and therapeutics education in Europe: A modified Delphi study. Clinical Pharmacology & Therapeutics, 2018 Aug;104(2):317-325. H. Shabbi, D. Soler, G. Grech, C. Saliba, D. Duca, I. Gabnar, J. Mifsud Modelling covariates which influence lamotrigine pharmacokinetics in Paediatric patients. Epilepsia, 58(Suppl. 5):S52, 2017 Mifsud, J. Medicine Adherence in the aging population - the role of pharmacokinetics and pharmacodyamics. in Adherence to Medical plans for Active and healthy Aging (Costa E., ed), 2017, p 149-164 Nova Publishers. Chneiweiss H, Hirsch F, Fenet S, Merchant J, Abecassis M, Botbol-Baum M, Baertschi B, Lanzerath D, Houghton JA, Mifsud J, Bartnik E, Rath J, Montoliu L, Kritikos M, Friedrich B, Saint-Raymond A, Druml A. Fostering Responsible Research with Genome Editing Technologies: a European Perspective. 2017, Transgenic Res (2017) 26:709713. Mifsud,M; Jickells,S; Mifsud J; Wolff,K. EcstasyTablets: Batch Matching for Forensic Drug Intelligence Purposes in Malta in Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation, Wolff K (ed) 2017, 288, Royal Society of Chemistry. Scerri AM, Soler DM, Calleja N, Vella Bonanno P, Mifsud J Pharmacoepidemiological aspects of the treatment of epilepsy in children. British Pharmacological Society Annual Conference December 2016 Mifsud J, Maliepaard M, Pharmacokinetics and Pharmacogenetics: bringing the magic bullet closer to reality. Chapter in Preventive and Predictive Genetics: Towards Personalised Medicine Grech G; Grossman I, Springer Press, 2015 p91-107. Baulac M, de Boer H, Elger C, Glynn M, Kälviäinen R, Little A, Mifsud J, Perucca E, Pitkänen A,
22/12/2020 European Medicine Agency Page 5/20 Ryvlin P. Epilepsy Research Priorities in Europe: A Report of the ILAE-IBE Epilepsy Advocacy Europe Task Force, Epilepsia, 2015 56(11): 1687-95. Sciberras JN, Galloway SD, Fenech A, Grech G, Farrugia C, Duca D, Mifsud J The effect of turmeric (Curcumin) supplementation on cytokine and inflammatory marker responses following 2 hours of endurance cycling.J Int Soc Sports Nutr. 2015 Jan 21;12(1):5. doi: 10.1186/s12970-014-0066-3. eCollection 2015.
Vella T, Mifsud J.Interactions between valproic acid and quetiapine/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring. J Pharm Pharmacol. 2014 Jan 7. doi: 10.1111/jphp.12209. [Epub ahead of print] Arzimanoglou A, Lagae L, Cross JH, Beghi E, Mifsud J, Bennett C, Schmidt D, Wait S, Harvey G. The administration of rescue medication to children with prolonged acute convulsive seizures in a non-hospital setting: an exploratory survey of healthcare professionals' perspectives Eur J Pediatr. 2014 Jan 3. [Epub ahead of print] Cross JH, Wait S, Arzimanoglou A, Beghi E, Bennett C, Lagae L, Mifsud J, Schmidt D, Harvey G Are we failing to provide adequate rescue medication to children at risk of prolonged convulsive seizures in schools? Arch Dis Child. 2013 Oct;98(10):777-80. doi: 10.1136/archdischild-2013-304089. Epub 2013 Jul 30. Wait S, Lagae L, Arzimanoglou A, Beghi E, Bennett C, Cross JH, Mifsud J, Schmidt D, Harvey G.The administration of rescue medication to children with prolonged acute convulsive seizures in the community: What happens in practice? Eur J Paediatr Neurol. 2013 Jan; 17(1):14-23. Mifsud J, Bellia C. COST: Matchmaking for Researchers. 2013 1(1) Xjenza 75-81. Sghendo L, Mifsud J. Understanding the molecular pharmacology of the serotonergic system: using fluoxetine as a model. J Pharm Pharmacol, (2012) J Pharm Pharmacol. 2012 Mar; 64(3):317-25. Mifsud J, Sghendo LJ. A novel chiral GC/MS method for the analysis of fluoxetine and norfluoxetine enantiomers in biological fluid. J Pharm Bioallied Sci. 2012 Jul;4(3):236-45. Mifsud J, The Effects of Antiepileptic Drugs in relation to Dentistry. The Dental Probe (The Maltese Dental Journal), 2012 Mar:41, 33-36. Mifsud J, Allocation of health care resources: justice and sustainability. in Bioethics and Society: A Brave New World? University Chaplaincy, University of Malta, 2012, 132-142. Mifsud, J. The effects of antiepileptic drugs in relation to dentistry The Dental Probe - The Maltese Dental Journal (2012) 41: 33-36. Baulac M, De Boer H, Elger C, Glynn M, Little A, Kalviainen R, Mifsud J, Perucca E, Pitkanen A. The Written Declaration on Epilepsy: An Important Achievement for Europe and Beyond. Seizure (2012) 2: 75-76 Mifsud J. Abuse of OTC and prescribed drugs: popping pills for thrills. J Malta Coll Pharmacy Practice (2011) 17: 16-20. Mifsud J, Malta: Facing the challenges. In Sudden unexpected death in epilepsy: continuing the global conversation. Chapman D, Panelli R, Hanna J, Jeffs T. (ed) Epilepsy Australia Ltd (2011) 123-124. Petr P, Mifsud J. Klinická farmakologie na Malt se pedstavuje (Clinical Pharmacology In Malta). Klin Farmakol Farm (2011) 25(3). Mifsud J, Attard D, Attard L. Doping in Maltese sports: a mountain or a molehill. Maltese Medical Journal. 2011: 16-21. Mifsud J. Phenobarbital and other barbiturates. The Atlas of Epilepsies. Chrysostomos P. Panayiotopoulos (Ed.) Springer Publications. 2010. vol 3, 1807-1812 Mifsud J. Primidone. The Atlas of Epilepsies. Chrysostomos P. Panayiotopoulos (Ed.) Springer Publications 2010. vol 3, 1825-1828 Baulac M , Aronica A, Ben-Ari Y, Bernard C, Brodie M, Chiron C, De Curtis M, Duncan J, Friedman A, Fritschy JM, Grçhn O, Guekht A, Kullmann H, KaleR, Kçhling R, Lerche H, Loscher H, Kokaia M, Marson M, Mifsud J, Ozkara C, Pitkanen A, Ryvlin P, Sander L, Semah F, Serratosa J, Shorvon S,Tomson T, Vezzani A. ILAE Commission on European Affairs. Research priorities in epilepsy for the next decade a representative view of the European scientific community. Epilepsia 2009; 3:
22/12/2020 European Medicine Agency Page 6/20 571-578. Ellul Darmanin R, Cordina M, Buhagiar A, Fenech A, Mifsud J. An analysis of gender differences in self-reported health, use of medicines and access to information sources about medicines among adolescents. Int J Adolesc Med Health 2009;4: 591-600. Mifsud J. The clinical relevance of pharmacokinetics and drug interactions with anti epileptic drugs. Journal of the Malta College of Pharmacy Practice 2009; 15: 22-28. Darmanin Ellul R, Cordina M, Buhagiar A, Fenech A, Mifsud J. Health complaints and use of medicines among adolescents in Malta. Pharmacy Practice 2008 Jul-Sep;6(3):165-170. Darmanin Ellul R, Cordina M, Buhagiar A, Fenech A, Mifsud J. Knowledge and sources of information about medicines among adolescents in Malta. Pharmacy Practice (Internet). 2008 Oct-Dec;6(4):178-186. Mifsud J, Gidal B. Clinical Pharmacokinetics of AEDs. Virtual Epilepsy Academy. VIREPA Clinical Pharmacology & Pharmacotherapy on-line education module 2007. Ihttp://www.eurepa.de/ilias3/repository.php?ref_ id=2170&cmd=view. Millership JS, Mifsud J, Galea D, McRoberts WC and Hamilton JT. Chiral aspects if the human metabolism of ethosuximide. Biopharmaceutics and Drug Disp 2005; 26: 225-232. Donaldson K, Glynn M Mifsud J et al., Epilepsy Action Pack: a tool for change. EUCARE. 2004. Mifsud J, Kavangh M. Science and Society: towards a new partnership. Proceedings of CASTME meeting: Linking Science Mathematics and Technology Education and their social relevance. 2002: 245-54. University of Malta Press. Sghendo L, Mifsud J, Ellul-Micallef R, Portelli J, Millership J. A sensitive gas chromatographic/ mass spectrometric method for the resolution and quantification of ethosuximide enantiomers in biological fluids. Journal of Chromatography B 2002; 772: 307-315. Mifsud J, Collier P, Millership JS. The pharmacokinetics of ethosuximde enantiomers in the rat. Biopharmaceutics and Drug Disp 2001; 22:83-89. Mifsud J, Millership JS, Collier PS, Morrow R, Hamilton JTG, McRoberts B. Quantification of urinary excretion of ethosuximide enantiomers and their major metabolites in the rat. Biopharmaceutics and Drug Disp 2001; 22:129-136 Mifsud J. invited Editorial. Pharmaceuticals and Health Care providers: meaningful links in a Mediterranean Context. Pharmaceutical Technology Europe 1999; 11 (3) 4. Millership JS, Collier PS, Mifsud J. Chiral aspects of metabolism of ethosuximide. Chirality 1995; 7:173-180. Mifsud J. Stereoisomeric pharmacovigilance and racemic drugs in hospital formularies. Medical Research Conference- perspectives in pharmacotoxicology and pharmacovigilance. Fracchia Ed. IOS Press. 1994: 331-343 Millership JS, Collier PS, Mifsud J. The metabolism of ethosuximide. European J of Drug Met and Pharmacokinetics 1993; 18(4): 349-353. other publications Mifsud J, Advisor Editorial Board, International Epilepsy News, 2009 - to date Lapira A, Sammut N, Scerri C, Cordina G, Mifsud J, Cassingena J, Saliba Scerri R, Castillo N. National Strategy for Health Research and Innovation, Malta Council for Science and Technology, December 2012. Mifsud J, A Strategic Plan for Epilepsy for WHO Europe. For International Bureau of Epilepsy, WHO 62nd Regional Committee for Europe, September 2012 Mifsud J, Ma tghallimtx bizzejjed. Flimkien, no 91, June 2012 M. Maliepaard, M. Ingelman-Sundberg, E. Gil Berglund, Tomas Salmonson, K. Oselin and J. Mifsud. Guideline on the use of pharmacogenetic methodologies in the pharmacokinetic evaluation of medicinal products. Pharmacogenetics Working Party, Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency, Jan 2012. Mifsud J, European Co-operation in Science and Technology. Malta Council for Science and Technology Annual Report, 2011, p 114-125. Schmucker von-Koch J, Charitidis C, Hirsch F, Houghton JA, Mifsud J, Morton D, OSullivan S, Rath J, Sutrop M. Lessons Learnt Ethics Review 2010. Report Commissioned by DG Research,
22/12/2020 European Medicine Agency Page 7/20 European Commission, Brussels, 2011 Mifsud J. Contributor. Epilepsy in the WHO European Region. Fostering Epilepsy Care in Europe. Global Campaign Secretariat. Sein. Netherlands 2010. Mifsud J, MPSA, MMSA, MDAS, What is Epilepsy. European Epilepsy Day information leaflet, March 2011 Mifsud J et al., What is epilepsy? Poster February 2011 Mifsud J et al. Teachers pack Understanding Epilepsy. March 2011 Mifsud J, Pfaffalin M, .Dimech V, Bekes J, Education for Professionals Allied To Medicine (PAMs) Working in Epilepsy. in press, 2011. Mifsud J, COST Networking with international peers in Research. Malta Council for Science and Technology Annual Report, 2010, p 54-55. Mifsud J. Patient Safety: Can we avoid medication errors?. Journal of EuroMed Pharmacy. April 2010. Mifsud J. Drugs and Sports : if in doubt, leave it out. MPSA overdose March 2010: Mifsud J. Drugs and Sports : what and what next? MPSA Overdose. March 2010. Mifsud J, Pfaffalin M, Dimech V, Hézser-v.Wehrs V. FAMOSES A Primer For Children With Epilepsy, (translated into Maltese). In press 2010. Mifsud J. Berlin: Brian Works: Epicure hosts its 3rd annual meeting in Berlin. International Epilepsy News. 2009; 1: 17. Mifsud J. The Ivory Tower at tal-Qroqq. Reaching out to the Lost Princes. MPSA Overdose March 2009: 12-13. Mifsud J. Education in general and the Education of People with Epilepsy. Regional Reports on epilepsy resources, ILAE/IBE/WHO Global Campaign against Epilepsy 2005. Mifsud J. Pharmacokinetics and pharmacodynamics in clinical practices; demolishing some misconceptions. Part 1 and 2. The Synapse, November 2004 and February 2005. Mifsud J. Dimech V, Dimech M, Portelli F. L-Epilessija u T-Tfal; L-Epilessija, L-Alkool, u S-Sewqan; L-Epilessija u L-in Liberu; L-Epilessija Fix-Xjuija; L-Epilessija u Xogol; enituri Bl-Epilessija; Mediini Uati Fl-Epilessija; In-Nisa u L-Epilessija; L-Epilessija: Gwida Gall-Galliema; Epilessija-Tista Tghix Hajja Normali; Education leaflets in Maltese for persons with epilepsy. 2004. Mifsud J. L-epilessija u s-Socjeta. EinKarem Volunteers Newsletter. Caritas Malta. 1(3) April 2004. Mifsud J Drugs and the athlete: What is the price for winning at any cost. Chronic-ill. Issue 7, Summer 2003. Mifsud J Pharmacy at the Movies. MPSAs Overdose. 2003; 2(3). Mifsud J. The Lost Princes: New Challenges For Eurepa. Eurepa Bulletin. 2003: 2-4. Mifsud J The new antiepileptic drugs the boring drugs. Synapse 2002. Mifsud J. Caritas Malta Epilepsy Association. Numerous press releases. http://www.caritasmalta.org/epilepsy/press.htm abstracts at conferences Sghendo L, Mifsud J, A novel method for the therapeutic drug monitoring of chiral fluoxetine in biological samples, Malta Medical School Conference, November 2012 Malta Medical Journal 24:S; P4.10 p 109. Mifsud J, Sustainable and accessible healthcare in Malta: the common good concept, Malta Medical School Conference, November 2012, Malta Medical Journal 24:S; OP7.199 p 68. Abela A, Cuschieri P, McElhatton A, Mifsud J, Drug sensitivity patterns of Streptococcus pneumoniae in the Maltese Islands, Malta Medical School Conference, November 2012, Malta Medical Journal 24:S; P6.05 p 121. Spiteri Fiteni C, Cuschieri P, McElhatton A, Mifsud J, Introduction of antimicrobial susceptibility testing to Campylobacter species and sub-species, Malta Medical School Conference, November 2012, Malta Medical Journal 24:S; P6.21 p 125-6. Farrugia C, Mifsud J, Familial febrile seizures (FEB): identification of a novel genetic locus on Chromosome 20, Malta Medical School Conference, November 2012 Malta Medical Journal 24:S; P4.06 p 107-8. Vella T, Mifsud J, Ellul Micallef R, Interactions between valproate and olanzapine/quetiapine in
22/12/2020 European Medicine Agency Page 8/20 bipolar disorder, Malta Medical School Conference, November 2012 Malta Medical Journal 24:S; OP8.227 p 77. Cardona P, Mifsud J, Drug in Sport: The Maltese Scenario, Malta Medical School Conference, November 2012 Malta Medical Journal 24:S; P1.19 p 98. Bellizzi M, Mifsud J, Cassar K, Post-operative pain management in amputation- the influence of timing analgesia. Malta Medical School Conference, November 2012 Malta Medical Journal 24:S; P9.03 p 140. Aquilina C, Cordina M, Vella Bonanno P, Mifsud J, Ellul-Micallef R, Compliance with th ew new Euroepan bioequivalence guidelines: development of a tool for assessment Malta Medical School Conference, November 2012 Malta Medical Journal 24:S; P1.20 p 98-99. Bartolo A, Mifsud J, Effectiveness of analgesia on the sequelae following dental procedures, 6th European Congress of Pharmcology, Granada Spain July 2012, P105 p58. Farrugia CM, Cassar M, Mifsud J, Identification of a novel genetic locus for febrile seizures in a Maltese family, 10th European Congress on Epileptiology, London UK October 2012. Chetcuti M, Mifsud J, Vella Bonanno P, Borg JJ. Quality issues arising during assessment on active pharmaceutical ingredients (APIs) in European Decentralised Procedure (DCP) applications. Workshop on Characterisation Of Active Pharmaceutical Ingredients. Joint Pharmaceutical Analysis Group (jointly sponsored by the Royal Pharmaceutical Society of Great Britain and the Royal Society of Chemistry). December 2010. Mifsud J, Shabbi H, Soler D, Using Adapt® in paediatric patients: pharmacokinetic modelling for lamotrigine. WorldPharma Conference. Copenhagen. 17-23 July 2010. Demsey J, Mifsud J. The Knowledge of and Attitudes toward Epilepsy amongst University Students in Malta. 9th European Congress on Epileptiology. Rhodes. June 2010. Mifsud J, Camilleri T, Galea R. Pregnancy, epilepsy and birth outcomes in females of child bearing age in Malta. 8th European Congress on Epileptilogy. Epilepsia 2009. 50;s4:71. Mifsud J, Cassar M. Linkage Analysis in a idiopathic epilepsy in Malta. International Epilepsy Congress. Budapest July 2009. Mifsud J, Cassar M. Linkage Analysis in a familial case of idiopathic epilepsy in Malta. Maltese Medical School Conference. Malta Medical Journal 2009; 21S: 173. Gauci H, Gauci JB, Borg A, Bugeja S, Mifsud J, Sciriha Aquilina I. The gender gap in science and technology in Malta evaluating the problem and tackling the issues. Proceedings of Pacem in Maribus XXXII Waves of Change: Women, Youth and the Sea. 2008 Mifsud J, Patient Safety. Can we avoid medication errors? Proceedings of Patient Safety- Developing Strategic Approaches. Commonwealth Medical Association 22nd -23rd February 2007. Malta. Mifsud J, Galea R, Camilleri T. A retrospective study of antiepileptic drug treatment in pregnancy and birth outcomes in Malta, a small island state. American Epilepsy Society 2007 Annual Meeting Philadelphia, PA. November 30 December 4, 2007. Mifsud J, Shabbi H, Soler D. Paediatric Pharmacokinetic modelling for sparse lamotrigine data using ADAPT®t. Epilepsia 2005; 46(S6):108. Dimech V, Dimech M, Mifsud J. Epilepsy as a hidden disability: organising an in service training course for educators in Malta. Epilepsia 2005; 46 (S6): 190. Mifsud J, Shabbi H, Soler D. Pharmacokinetic modelling for sparse lamotrigine data using adapt in paediatrics. J Clin Pharmacol 2005; 45:1068. Mifsud J,, Gafa M, Micallef M, Galea Debono A Ellul-Micallef R. Effect of anti epileptic drugs on in vitro lymphocyte proliferation assay. Epilepsia 2004; 45(S3):127. Sghendo L, Mifsud J,, Ellul-Micallef R, Portelli J, Soler D. Pulmonary Uptake of Chiral Antiepileptic drugs. Proceedings 8th Mediterranean Epilepsy Conference 17-20th November 2004, Marrakesh, Morocco. Mifsud J, Messina Fenech R. Pharmaceutical Overdose in Malta. Malta Medical Journal. 2003; 2: 2. Mifsud J, Soler D. Psychopharmacology in child disability. Malta Medical Journal. 2003; 2: 27. Mifsud J, Pace T, Cali-Colero R. The use of non sedating antihistamine in a hyperbaric environment. Malta Medical Journal. 2003; 2: 27.
22/12/2020 European Medicine Agency Page 9/20 Sghendo L, Mifsud J,, Ellul-Micallef R, Portelli J, Soler D. Pulmonary Uptake of Chiral Antiepileptic drugs. Proceedings 25th International Epilepsy Congress, Lisbon. Epilepsia 2003; 44,(S8):174. Mifsud J, Sghendo L, Pulmonary Pharmacokinetic studies of a chiral drug in an animal model. Malta Medical Journal 2003;15(2): 27. Mifsud J, Dimech M, Debattista A, Cachia G. Caritas (Malta) Epilepsy Association: On The Side Of People In Need. Abstract in Proceedings. 8th Epilepsy and Society meeting, Spain, May 2002. Mifsud J, Gafa M, Micallef M. Traditional and new AEDs effect on in vitro lymphocyte proliferation assays. European Journal of Pharmaceutical Sciences 2002; 17(S1):68. Gafa M, Mifsud J,, Micallef M, Debono AG ,Ellul-Micallef R. Determination of IGE levels in patients with epilepsy. 5th Congress of the European Association of Clinical Pharmacology and Therapeutics 12-15 September 2001. Pharmacology and Toxicology 2001; (89): S1. Mifsud J, Cauchi N, Tanti Burlo E, Soler D. Antiepileptic drug treatment and sense of coherence in children with epilepsy. Epilepsia 2001; 42(S2): 86. Gafa M, Mifsud J, Micallef M. Determination of immunological levels in patients with Epilepsy. Fundamental and Clinical Pharmacology 2001; 15 (S1):26. Mifsud J, Cauchi N, Tanti Burlo E, Soler D. The impact of pharmacological therapy on coping strategies: a health care team approach for children with epilepsy. 2nd Spring Conference on Clinical Pharmacy -Pharmacy Practice to meet patients needs. 2-5 May 2001 Malta:13. Gafa M, Mifsud J, Micallef M. Modification in Immunological levels in patients on new antiepileptic drugs Epilepsia 2001; 42 (S2): 40. Mifsud J, Cauchi N Tanti Burlo E Soler D. Antiepileptic drug treatment and sense of coherence in children with epilepsy. Epilepsia 2001; 42(S2):86. Gafa M, Mifsud J, Micallef M. Determination of Immunological levels in patients with Epilepsy. Fundamental and Clinical Pharmacology 2001; 15(S1): 26. Sghendo L, Mifsud J, Millership JS, Collier PS. A novel GC/MS for the quantification of ethosuximide enantiomers in biological samples. Eur J Pharmaceutical Sciences 2000. 11: S72. Mifsud J,, Collier, PS, Millership JS. Pentylenetetrazol (PTZ) infusion model for the determination of the stereoselective protective effects of antiabsence antiepileptic drugs. European Journal of Pharmaceutical sciences 1999 8(2): ix. Mifsud J,, Buttigieg A, Debono AG, Micallef RE. Therapeutic management with the newer antiepileptic drugs in Malta. Epilepsia 1999; 40(2):96. Mifsud J Cauchi N, Tanti Burlo E, Soler D. Concerns, coping behaviour and sense of coherence in parents of children with epilepsy. Epilepsia 1999; 41: 152 Mifsud J,Collier PS, Millership JS. Animal models in the determination of stereoselective protective effects of chiral antiepileptic drugs. Archives of Pharmacology 1998; 358 (S1): R33. Mifsud J, Mizzi M. Assessment of population kinetic software in clinical population outpatient setting. Archives of Pharmacology 1998, 358 (S2): R457. Millership JS, Collier PS, Mifsud J. Improving therapeutic outcomes: focus on chiral anti-epileptic drugs. Epilepsia 1997;38(3): 65 Mifsud J, Marshall K, Cassar E. Integration of population kinetic software in clinical practice: an assessment. Therapeutic Drug Monitoring 1997; 19(3) 103. Millership JS, Collier PS, Mifsud J. Pentylenetetrazol (PTZ) infusion model for the determination of the stereoselective effects of antiabsence antiepileptic drugs. ISSX 1997; 106 Millership JS, Collier PS, Mifsud J. Kinetics of (R)- and (S)-ethosuximide in the rat. European J of Drug Met and Pharmacok 1996;(S1):59. Mifsud J, Ebejer T. Implementation in clinical practise of new pharmacological knowledge on racemic drugs. International Union of Pharmacology, XII Congress, Abstract in proceedings, Canadian J Physiology and Pharmacology 1994: 72; S1: 610. Millership JS, Collier PS, Mifsud J. Investigations into the metabolism of the enantiomers of ethosuximide. Pharmacokinetics: from theory to practice. Abstract in Proceedings NATOASI School, Erice, Sicily, 5-16 April 1994. Mifsud J, Cordina M, Sant Fournier M, Serracino Inglott A. The pharmacist in Malta, professional practice and education aspirations. Proceedings of 7th International workshop on Social Pharmacy,
22/12/2020 European Medicine Agency Page 10/20 Royal Holloway and Bedford College, University of London, July 1992. Mifsud J, Ebejer T, Serracino Inglott A. Incidence and management of adverse drug effects in a geriatric residence in Malta. Proceedings of Research residential symposium, UKCPA, November 1992: 55-56. Mifsud J, Millership JS, Collier PS. Stereoisomeric drugs and the elderly. Proceedings of the 3rd International Symposium on Chiral Discrimination, Germany, October 1992: 101
Projects o Workpackage Leader, H2020 Gender Action GENDer equality in the ERA Community To Innovate policy implementatiON. Coordination and Support Action SwafS-19-2016 No 741466. (2016 -2020) o Workpackage leader Parter, Erasmus+, IT-based international diploma and professional certificates in clinical toxicology (ITCT) (KA2 561915-EPP-1-2015-1-EG-EPPKA2-CBHE-JP) o Chair, Dissemination board and Ethics Board of an 11 million euro EU funded FP7 Project DESIRE Development and Epilepsy Strategies for innovative research to improve Diagnosis, Prevention and Treatment in children with Difficult to Treat Epilepsy (Health-F2-602531-2013) o Partner, LLP Erasmus Network, Science for Prevention Academic Network (SPAN) ((595,000) o Partner, Leonardo Da Vinci LLP EU project on disability education (16,000 euros) o Chair, Dissemination board of a 10 million euro EU funded FP6 project EPICURE: Functional Genomics and Neurobiology of Epilepsy: A Basis for New Therapeutic Strategies (LSH-037315). o $22,000 dollars from UNESCO; o 5000 euros from National Commission for Persons with Disability o 30,000 euros on a EYIE Epilepsy Youth in Europe YOUTH project, o 10,000 euros on a Grundtvig project; o 20,000 euros from University of Malta Research Committee. member of the External Advisory Board for the following projects: o Synanet EU funded H2020 Twinning project Neurologic and Psychiatric Disorders: from synapses to network No 692340 2015-2018 o IMI2 NeurodeRisk Neurotoxicity De-Risking in Preclinical Drug Discovery 2019-2023
Memberships MEMBERSHIP OF PROFESSIONAL AND LEARNED SOCIETIES BPS, Fellow, British Pharmacology Society EPHAR, Member, Federation of European Pharmacological Societies IUPHAR, Member, International Union of Pharmacology Founder Member, Caritas Malta Epilepsy Association (affiliated to International Bureau of Epilepsy) Founder Member and Secretary, Epilepsy Society of Malta (affiliated to International League Against Epilepsy) Member, Pharmacokinetics UK
CONFERENCES MEMBER ORGANIZING COMMITTEE: INTERNATIONAL CONFERENCES AND WORKSHOPS Invited Poster Reviewer and Chair, British Pharmacology Society Annual Meeting, December 2018. Member Organising and Scientific Committee EpiXchange: a community building event for epilepsy researcg, 23-24 May 2018 Member Organising Committee Novel Routes for the Analysis of Epilepsy ITN networks 30 April- 2nd May 2018, Malta Invited Poster Reviewer, British Pharmacoology Society Annual Meeting, December 2017. Member Scentific Committee, Mediterranean Federation for Rehabilition Medicine Conference, 13-17 November 2017 Member Organising Committee DESIRE Annual Meeting, 17-19 October 2017, Malta Member Organising and Scientific Committee 3rd Africian Epilepsy Congress Dakar 12-14 May 2017 Member Organising and Scientific Committee Malta EU Presidency EuroNanoForum 13-16 June 2017 Member Organising and Scientific Committee Epilepsy and Society Conference 11-13 September
22/12/2020 European Medicine Agency Page 11/20 2016
Member Scientific and Organizing Committee SPAN Final Conference Brussels 2 March 2016 Chair, Organising Committee, MOTION The transition of young persons with disability from school to the workplace, EU Life long learning project Malta 26-31 March 2014.
Member Scientific and Organizing Committee, Epilepsy and Society Conference, Ljubljana, Slovenia August 2013 Member Scientific and Organizing Committee, European Forum on Epilepsy Research, under the Irish EU Presidency Ireland, May 2013 Member, Scientific Advisory Committee, EPHAR, European Union of Pharmacology Conference 2012, Granada, Spain Member Scientific and Organizing Committee, International Congress on Epilepsy, Rome, Italy, August 2011 Invited participant. European Epilepsy Day. Strasbourg 14-15 February 2011 Co-ordinator. Eurepa 6th Pan European Train the Trainers course. Malta October 2008. Co-ordinator. Curricular Education for Professionals Allied to Medicine (PAMS) Working in Epilepsy Grundtvig Meeting. Berlin, 25-29 January 2006 Co-ordinator. Curricular Education for Professionals Allied to Medicine (PAMS) Working in Epilepsy. Grundtvig Meeting. Budapest, 3-6 June 2005. Co-ordinator Curricular Education for Professionals Allied to Medicine (PAMS) Working in Epilepsy. Grundvig Meeting. Bielefeld. 7-9 April 2005 Co-ordinator and organiser. EYIE Epilepsy Youth in Europe EU Youth Project. Malta. 1-8 September 2004. Member Organising Committee and chair. Sixth European Conference on Epilepsy and Society, Malta. 19-20 March 2004. Course co-ordinator: Pharmacokinetic School for the Pharmaceutical and Biomedical Scientist. Organised in collaboration with the University of Minnesota and University of Pisa. 6-15 September 1998. Malta. Member, Scientific Committee. Mediterranean Epilepsy Meeting. Montpellier, France. 4-6 September 1997
MEMBER ORGANISING COMMITTEE: LOCAL CONFERENCES AND WORKSHOPS Member Scientific Committee. 11th Maltese Medical School Conference. Malta. December 2018. Chair and Coordinator. National Conference Malta Caritas Epilepsy Association, Epilepsy: Finding Help. 10 March 2018. Chair and Coordinator. National Conference Malta Caritas Epilepsy Association, Living with epilepsy, Step by Step, 13 February 2016. Member Scientific Committee. 10th Maltese Medical School Conference. Malta. December 2015. Chair and Coordinator. National Conference Malta Caritas Epilepsy Association, Epilepsy is more than just seizures ? 22 February 2014. Member, Organising Committee. Drug use in the Older Person. Malta October 2013 Chair and Coordinator. National Conference Malta Caritas Epilepsy Association, Epilepsy - How do we overcome stigma? 25 February 2012. Organiser . European Epilepsy Day on Campus. 4 March 2011 Chair and Coordinator. Pharmacology Graduate Student Meeting EPHAR sponsored Pharmacology workshop, University of Malta, 15 September 2010 Chair and Coordinator. National Conference Malta Caritas Epilepsy Association. What is epilepsy? Improving our knowledge Malta. 20 February 2010. Member Scientific Committee. 7th Maltese Medical School Conference. Malta. December 2009. Chair and Coordinator. Epilepsy: a Multidisciplinary Approach. National Conference Caritas Malta Epilepsy Association. Malta. 9 February 2008 Chair and Coordinator. Epilepsy for teachers. In service teacher training course in conjunction with
22/12/2020 European Medicine Agency Page 12/20 Ministry for Education. Malta. 2005, 2006, 2007, 2008, 2009. Chair and Coordinator. Epilepsy for Nurses Epilepsy and the Nursing Profession. Malta. 16 November 2007. Organiser, Curricular Education For Professionals Allied To Medicine (PAMS) working in Epilepsy. Grundtvig conference Malta and Gozo. June 2006. Chair and Coordinator. National Conference Malta Caritas Epilepsy Association. Ten Years of Work - The Social Impact of Epilepsy, 18 February 2006. Malta Member, Scientific Committee. 6th Maltese Medical School Conference. December 2006. Chair and Coordinator. Malta, Epilepsy and Children - Together We Will Succeed. Caritas (Malta) Epilepsy Association. Malta. 22 February 2003. Chair and Coordinator. Epilepsy in the Open--Experiences in Malta. Caritas(Malta) Epilepsy Association National conference. Malta. 3 November 2001. Member, Organising Committee. Sports - the role of science and Medicine. Malta. 9-11 June 2000.
INVITED PARTICIPATIONS AND PRESENTATIONS AT INTERNATIONAL CONFERENCES AND MEETINGS Invited Speaker. Social Care Forum. European Epileptiology Congress. August 2018 Vienna Austria. Invited Speaker. ENERI. RI/RE expert qualifications consencus conference. Athens, Greecn 12 June 2018. Invited Speaker, Synanet Twinning Project. January 2018 Lisbon Portugal Invited Speaker, Mediterranean NeuroScience Conference May 2017, Malta Invited Chair, Virepa Session on Therapy in Epilepsy, 12th European Congress on Epileptology, Prague September 2016 Invited Speaker Tackling the Worlds drug problem ESOF Manchester 23-26 July 2016 Invited participant Expert Group for core undergraduate pharmacology curriculum Delphi Process British Pharmcological Society. London 24 Jun 2016 Invited Speaker, DESIRE Epilepsy Project. Residential International Course on Drug Resistant Epilepsies, Tagliacozzo Italy 6-12 May 2016 Invited Participant European Patient Forum Annual Conference Brussels 22-23 March 2016 Invited participant Better research for better healthA holistic approach to challenges & opportunities 1st Annual Conference of the Scientifc Panel for Health Brussels 21 January 2016 Invited speaker SPAN final conference Brussels 2 March 2016 Invited Participant Researcher Mobility in Drug Discovery Chicheley Hall Milton Keyes UK organised by BPS, BioChemical Society and RCS. 7-8 December 2015 Invited Speaker Womens Forum CHOGM Malta 22-24 November 2015 Invited Speaker Epiexchange epilepsy conference, Ferrara, Italy 27-30 Nov 2015 Invited Speaker, FP7 DESIRE Second annual meeting Germany 5-7 October 2015 Invited Chair 31st International Epilepsy Congress Istanbul Turkey 5-9 September 2015 Invited Chair EAPCCT Malta Congress European Association of Poisons Centrea dn Clinical Toxiciology 25-29 May 2015 Invited Speaker, FP7 DESIRE First annual meeting, Florence Italy 19-20 October 2014 Invited participant. Preconference Education Satellite Symposium. International Union of Pharmacology Conference. Cape Town South Africa 12-13 July 2014 Invited Speaker, Living beyond Epilepsy a resource for educators. Best practices on chronic patients and organisations empowerment. The role of citizens' organisations in the empowerment of patients with chronic diseases 8th European Patients Rights Day Brussels 12-13 May 2014. Invited Speaker, DESIRE Epilepsy Project. Residential International Course on Drug Resistant Epilepsies, Tagliacozzo Italy 4-10 May 2014 Invited Speaker, MOTION The transition of young persons with disability from school to the workplace, EU Life long learning project Ankara and Kasthamonu Turkey 22-26 May 2014. Invited Participant. Team Europe Training Seminar Brussels, 18-19 February 2014. Invited participant. European Epilepsy Day. Strasbourg 3-5 February 2014
22/12/2020 European Medicine Agency Page 13/20 Invited Participant, Health Technology Assessment-body workshop on parallel scientific advice in drug development. European Medicines Agency, London 22 November 2013 Invited Speaker, Health NCP NET , Malta Council for Science & Technology (MCST) Malta January 2013
Invited Chair, Antiepileptic drugs session, 10th European Congress on Epileptology, London 2012 Invited Participant, 62nd Session of the WHO Regional Committee for Europe Malta 10-13 September 2012. Invited Participant and Chair, Use of Medicines, 5th European Public Health Conference, Malta November 2012 Inviter Trainer, FP7 Thebera Project, Theodore Bilharz into the European Research Area, Cairo Egypt July 2012 Invited Participant, Patient Organisations Working Committee, European Medicines Agency, 7 May 2012 Invited Participant, PERFECT initiative, Viropharma, Brussels, Jan 2012, May 2012 Invited Speaker, OTC SOCIOMED EVALUATION MEETING Assessing the Over-The-Counter Medications in Primary Care and Translating the Theory of Planned Behavior into Interventions, Current situation of Prescription medicines in EuropeGreece, 16 December 2011 Invited participant, Euroepinomics ESF Project, Antwerp, Belgium, December 2011. Invited chair. 5th Golden Helix Pharmacogenomics Day, University of Malta, 3 December 2011 Invited Participant, Health Advisory Workshop on Common Strategic Framework HEALTH Brussels, 6-7 July 2011 Invited Participant. Joint task force on Epilepsy Research and Advocacy, ILAE IBE , Brussels 11 March 2011 Invited participant. Women in Leadership workshop. British Pharmacology Society, London 8 March 2011 Invited Speaker. SESTI EU FP7 e-foresse project. Scanning for Emerging Science and Technology Issues. Novembe 2010. Invited participant. SEIZE advisory panel. Glaxo Smith Kine, London UK September 2010. Invited Chair and Participant. 12th European Conference on Epilepsy & Society. Porto Portugal, August 2010. Invited Participant. 9th European Epileptiology Congress. Rhodes. July 2010 Participant. 16th World Congress of Basic and Clinical Pharmacology. Copenhagen, Denmark, July 2010. Invited participant. Italian Epilepsy League annual conference. Mantova May 2010 Invited Participant. IBE International Executive Committee Meeting, March, Ghent, Belgium 30-31 March 2010. Invited participant. Fourth Network Meeting. EPICURE FP6 Marseille France. 29-30 January 2010. Invited Participant. IBE International Executive Committee Meeting, Rome Italy 22-23 November 2009 Invited Speaker. From basic knowledge to rational prescribing in epilepsy. Academic exchange under Italo Malta Cultural Agreement 20-29 October 2009. Sapienza University of Rome II Faculty. Invited Speaker and participant. 28th International Epilepsy Congress. Budapest, Hungary, July 2009. Invited Speaker and Erasmus lecturer. Queens University of Belfast. 14-18 June 2009. Invited Participant and speaker. The visually-induced seizures Marie Curie Workshop Rome 27-28 November 2008. Invited Participant. 8th European Congress on Epileptology. Berlin Germany, 21-25 September 2008. Participant. IX World Conference on Clinical Pharmacology and Therapeutics. Québec City, Canada. 27 July 1 August 1 2008. Invited Participant. EMEA Workshop On Modelling In Paediatric Medicines 14-15 April 2008, London.
22/12/2020 European Medicine Agency Page 14/20 Invited Participant. Second Network Meeting EPICURE FP6: Functional Genomics and Neurobiology of Epilepsy: A Basis for New Therapeutic Strategies Malta, 30-31 January 2008. Invited participant. EC Workshop on Epilepsy Research in Europe in the Next Decade. Brussels. 17-18January 2008. Invited Participant. American Epilepsy Society Conference. Philadephia, US. 1-5 December 2007. Invited Chair. Womens Ocean Caucus. Pacem in Maribus XXXII Waves of Change: Women, Youth and the Sea conference. 7 November 2007. Malta. Invited speaker. Epilepsy : a case study in research and disability. Mediterranean with no handicap: Towards a new humanism ethics and disability. Malta. April 23-25 2007. Invited speaker. Medication Errors. Patient Safety Developing Strategic approaches. WHO conference, Malta. 2 February 2007. Invited Participant. American Epilepsy Society conference. San Diego. December 2006. Invited participant. Gender and Science. EPWS conference, Brussels. 20 October 2006. Invited Speaker and Chairperson. 10th European Epilepsy and Society Conference. Copenhagen Denmark. 1-4 August 2006. Invited participant. SIMCYP® training course. Basel July 2006. Invited participant and Speaker. European Congress on Epileptiology. Helsinki Finland 2-5 July 2006. Invited participant. First Network Meeting. EPICURE FP6 IP Venice Italy 11-15 January 2006. Invited Speaker. Gender and the Digital Divide, Commonwealth Civil Society Meeting, CHOGM, November 2005, Malta. Invited Speaker. Drug Therapy in Epilepsy: New perspectives, new implications. Epilepsy Programme Research Seminar, Hospital for Sick Kids, Toronto. 16 September 2005. Participant. 34th American College of Clinical Pharmacology. Rockville, US. September 11-13 2005. Invited Speaker. EUCARE Call to Action Workshop. 26th International Epilepsy Congress, Paris. 28 August 1 September 2005. Invited national contact point. RTD evaluators meeting. Luxembourg Presidency . 10-11 April 2005. Participant. European Association Of Faculties Of Pharmacy (EAFP) Annual Conference - Partnerships In Education: Science And Practice 9 - 12 March 2005, Malta. Invited Speaker and Erasmus lecturer..Queens University of Belfast. 21-24 November 2004. Invited Chair. 8th Mediterranean Epilepsy Conference. Marrakesh, Morocco. 17-20 November 2004. Invited speaker.Curricular education for PAMs. European Epilepsy Academy. Brussels, Belgium. 16 October 2004. Participant. 8th World Congress on Clinical Pharmacology & Therapeutics. Brisbane, Australia. 1-6 August 2004. Participant. 13th International Social Pharmacy Workshop. July 2004. Malta Invited Speaker. 6th European Congress on Epileptiology. Vienna May 2004 Invited Expert. First European Health Forum, Brussels, May 2004. Invited participant. Pharmacokinetics ADAPT ® workshop. Wittenberg Germany April 2004. Invited participant. NatMedNet Erasmus workshop. Amsterdam, Holland December 2003. Participant. 1st International Spring Symposium European Academy of Dermatology and Venerology, EADV. Malta. 27 February - 1 March 2003. Invited participant. Pharmacokinetics UK. November 2003 Liverpool. Invited Speaker: IBE workshops. Infleuncing public policy; Public relations. World Congress on Epilepsy, Lisbon Portugal, October 2003. Invited speaker. Pharmacokinetics of AEDs. International Course: From Basic Knowledge To Rational Prescribing In Epilepsy. Venice, Italy. 9-18 July 2003. Invited participant. GALENOS Erasmus workshop. Kings College London. 28-29 June 2003. Invited speaker. Committee Meeting on White Paper On Epilepsy: Call To Action. London, UK. 17 January 2003. Invited participant. Launch of Sixth Framework Programme for Research And Development. Brussels, Belgium. 1-3 November 2002.
22/12/2020 European Medicine Agency Page 15/20 Invited Speaker. Drug therapy in epilepsy: new perspectives new implications Symposium New vistas new perspectives in epilepsy research. Institute of Physiology Charite, Berlin. 31 October 2002. Participant. 7th European Congress of Pharmaceutical Sciences. October 21-23 2002. Stockholm, Sweden
Invited speaker. 5th European Congress on Epileptiology. Madrid, Spain. 6-10 October 2002. Participant. AiBST course on ADME for drug discovery and development. Cape Town. South Africa. 18-23 August 2002. Invited Chairperson. Sessions on Interdisciplinary task in Epilepsy and White Paper on Epilepsy: Call to Action. Epilepsy and Society meeting. Loret de Mer, Spain, May 2002 Participant .GALENOS workshop; University of Saarbrucken Germany, February 2002. Invited Speaker. Graduate Potential Seminar. University of Malta. February 2002 Participant. Eurepa Train the Trainers workshop. European Epilepsy academy, Bielefeld, Germany, January 2002. Invited participant and speaker. Women in the Life Sciences: Tools for Successful Research Careers Stockholm, Sweden December 3-4, 2001 Participant. EPHAR Congress, Lyon, France, July 2001 Participant, 24th International Epilepsy Congress, Buenos Aires, Argentina, 13-18th May 2001. Participant. British Pharmacological Society Winter Meeting 2000 Birmingham, UK December Participant. XIII International Congress of Pharmacology, 26-31 July, 1998 Munich, Germany. Invited Participant. Women in Science Conference. European Union, DG XII, Brussels 28-29 April 1998. Brussels.Belgium. Invited Speaker. Pharmacokinetics UK meeting. Manchester, UK. October 1998. Invited Participant . Epilepsy in Maltese children - strategies for integration and education. International Conference in Inclusive Schooling and Communities. Malta 23-26 July 1997. Invited Participant. Creativity vs. serendipity. Thinking skills in the sciences. 3rd International Conference on Creative Thinking. 28 -29 July 1997. Malta Participant. Anti epileptic drug treatment - state of the art and further perspectives. 8th International Bethel-Cleveland Clinic Epilepsy Symposium, Bielefeld, April, 1997. Participant. Pharmacokinetics UK Workshop, Russ Hill, London 6-8 November 1996. Participant. 2nd European Congress on Epileptiology The Hague, Netherlands, 1- 5 September 1996. Participant and nominated for Nominated for Jean Hirtz Award. 6th European Congress of Biopharmaceutics and Pharmacokinetics, Athens, Greece. 22-24 April 1996. Invited Lecturer. Chiral aspects of the disposition and pharmacology of the enantiomers of ethosuximide. School of Pharmacy. Queen's University of Belfast. November 1995. Participant. Stereoisomeric pharmacovigilance and racemic drugs in hospital formularies. Paper presented at the 1st Medical Research Conference- perspectives in pharmacotoxicology and pharmacovigilance, EU commission, Brussels 6-7 December 1993. Participant. The pharmacist in Malta, professional practice and education aspirations. Paper presented at the 7th International workshop on Social Pharmacy, Royal Holloway and Bedford College, University of London, July 1992. Participant. Pharmacology education for the pharmacist in Malta - from the science to the patient. XI International conference on Pharmacology, IUPHAR, 1-7 July 1990, Amsterdam, Netherlands.
6.5 INVITED PARTICIPATIONS AND PRESENTATIONS AT LOCAL CONFERENCES AND MEETINGS Invited Chair, Molecular Sciences Session Malta Medical School Conference, November 2012 Co-ordinator, Department of Clinical Pharmacology and Therapeutics events, Discover University, University of Malta, Invited Trainer, November 2012 Invited Speaker, What is epilepsy. Malta Employment Training Co-operation, Malta, September
22/12/2020 European Medicine Agency Page 16/20 2012 Invited Speaker, What is epilepsy. Dar il-Kaptan Hospice, Mtarfa, Malta, 21 May 2012 Invited participant, National Conference, National Antidoping Organisation, March 2012. Invited Speaker, Prohibited Substances and Health Consequences, Anti Doping Seminar, National Anti-Doping Commission, Malta 14 February 2012 Invited Speaker, Epilepsy: the falling sickness in literature and in the movies. Joint meeting: HUmanities and the Medical Sciences, University of Malta, 27 January 2012 Invited Chair, Golden Helix, Pharmacogenetics Day, 3 December 2011 Invited participant, Seminar on Intractable Epilepsy and Ketogenic diet, Malta 18 October 2011 Trainer. What is Epilepsy. Malta Police Academy. Fort St Elmo Malta. February-March 2010, October 2010, November 2011. Invited Speaker, Ethical and Regulatory issues in Pharmacogenetics, Malta College of Pharmacy Practice, November 2011, October 2012. Invited Speaker. What is epilepsy. Gozo seminar, Oasi Foundation. October 2010 Invited speaker. Neuroscience Seminar Day. University of Malta June 2010 Invited Speaker. What is the EU? Team Europe. Malta. May 2010 Invited Speaker. Malta Pharmaceutical Students Association Annual Conference. December 2008. Invited participant. ESF Research & Mobility Action Plan to develop in-house R&I Capacity. FORLINK Final Networking Event. MCST November 2008. Invited Speaker. Institute of Health Care Interdisciplinary Seminar Date: Saturday, 23rd February 2008 Invited Chair. National Conference on Life long Learning. Malta 24 February 2007 Invited Participant and Chair. Committee National Action Plan On Health And Long-Term Care Consultation Process. Ministry for Health. Malta. May 2006 Invited Speaker. Epilepsy in Maltese Education, Heads of Primary and Secondary Schools. Malta. 23January 2006 Invited Speaker: Drugs and the sports athlete. Hosted by Malta Olympic Committee, Malta. January 2004. Invited Trainer. Epilepsy. Staff Development Programme Eden Foundation,. Malta 3 November 2004. Participant. International Conference on infection control and antibiotic therapy. Malta. November 2003. Invited Participant. Seminar on Risk Assessment and Toxicology. Malta Standards Authority. Malta. 10-13 June 2003. Invited Speaker: Epilepsy and Medicines. Dar tal-Providenza. Malta. 18-25 March 2003. Invited participant. 1st International Spring Symposium European Academy of Dermatology and Venerology, EADV. Malta. 27 Feb- 1March 2003. Member. Medical Commission. GSSE Small Nation Games of Europe. Malta June 2003. Invited Speaker. Medicines Advisory Board. Malta. May 2003 Invited speaker. Drugs And The Female Athlete: Whats New? MOC/KMS conference on Women And Sport: For a Better Life. Malta. 22- 24 November 2002 Invited Speaker. CASTME Meeting: Linking Science mathematics and technology Education and their social relevance. Malta. 10-13 April 2002. Coordinator. Workshop on Interpersonal relationships and team building. Ghaxaq Primary School. Malta. November 2001. Invited Speaker. Disability Fair. Naxxar Trade Centre. Malta May 2001 Invited Speaker. Bioethics and Interprofessional Ethics. Bioethics Consultative Committee Malta. 24 November 2000. Invited speaker. Epilepsy and school children. Church Schools Social workers. Malta. May 2000. Invited speaker. Women and Science. Malta Council of Women. Malta. May 2000. Invited Speaker. Epilepsy as a disability. Caritas Regional Meeting. Malta. October 1999. Invited Lecturer. Techniques in gas chromatography/ Mass spectrometry. Training course for graduate Libyan students. Malta. July 1999.
22/12/2020 European Medicine Agency Page 17/20 Invited Participant. European Pharmaceutical Students Association Meeting. Malta. 5-12 April 1999. Participant and oral presentation. IV Maltese Medical School Conference. Malta. 11-13 March 1999. Invited Participant. A preliminary assessment of MDMA use in Malta. ICAA 1998, Malta September 1998. Invited Chairperson. Pharmacy Students symposium. Malta. 27-31 March 1998. Invited Participant. Strategies for integration and education for Maltese children with Epilepsy. Facilitators course, 19-20 February 1998. Oration, Graduation Ceremony, University of Malta. 21 November 1997. Invited Participant. Epilepsy in Maltese children - strategies for integration and education. International Conference in Inclusive Schooling and Communities. Malta. 23-26 July 1997. Invited Participant. Euromed networking in substance abuse prevention. Sedqa, Malta. 31 October 1997. Invited Participant. Drug treatment in children with epilepsy. In-service course for nurses. Health Education Division. Ministry of Education. July 1997. Malta. Participant. Forum for Science Teachers. Chamber of Scientists. University of Malta. 6-18 September 1996 Participant. Gender Issues in the curriculum - a game of chess - presentation at Committee for gender issues workshop. 11 December 1996. Participant. Edward de Bono Seminar in Creative Thinking. 29-31 July 1996. Invited Participant. Current perspectives in research on drug and alcohol abuse in Malta. 3 May 1996. Invited Speaker. Volatile substance abuse - inhalants. Conference on Alcohol and other drugs. Malta. 1-2 March 1996. Participant. Promoting 'stereoisomeric awareness'. 2nd International Symposium on the role of the Pharmacists in Health Promotion and Disease Prevention. 21-23 March 1996 Participant. Symposium on Life Science and Biotechnology. Malta Council of Science and Technology. 23-24 February 1996. Participant. Women in Science. Science Week, Malta Council of Science and Technology. University of Malta. 15 -21 January 1996 Participant. Cyclodextrins in chiral separation techniques. Paper presented at Symposium for graduate students in Pharmacy. University of Malta. 5-7 March 1993. Participant. Therapeutic drug monitoring of digoxin- SIMKIN in Clinical Pharmacy - Computers beyond, University of Malta, 16 December 1991. Chairperson, Pharmacokinetics session, Pharmacy Students symposium, University of Malta, March, 1991. Participant. Enantiomeric Drugs and the Elderly. 1st International congress on Drugs in the Elderly, 17-20 March 1991. Chairperson. Pharmacokinetics session, Pharmacy Students Symposium, University of Malta, March, 1990.
OTHERS Member, Malta US Alumini Association, 2011- to date Astronomy Society of Malta 1982- to date MENSA 1994- to date Soroptomist International (Malta branch), 1997-2000 Presenter and producer, Health Education TV programme. November 1999-June 2000 Presenter and producer, Health Education Radio programme. January 2001-June 2003 Invited Speaker on several national radio and TV programmes, 2004- to date
22/12/2020 European Medicine Agency Page 18/20 Other Relevant Information INVITED EXPERT EVALUATOR AND REVIEWER
Invited expert evaluator, Science Fund of the Republic of Serbia, 2019, 2020 Invited expert evaluator, EIT Health proposals, 2016 2017 2018 2019 2020 Invited expert evaluator, Fundación Bancaria Caixa Destalvis I Pensions De Barcelona La Caixa, 2018, 2019, 2020 Invited expert evaluator, Polish Research proposals 2016 Invited expert reviewer, H2020 research and ethics proposals, 2014, 2015, 2016, 2017, 2018, 2019, 2020 Invited expert reviewer. FP7 Human Brain Project DG Connect Brussels 2015 Invited expert evaluator, Czech Norway Research proposals 2014 Invited expert reviewer. EPIPGX FP7 project. DG Research, EU Commission, Brussels 2014. Invited expert reviewer. FP7 Heath Innovation Panels. DG Research, Brussels, 2014. Invited expert evaluator. FP7 Heath Innovation Panels. DG Research, Brussels, 2012, 2013, 2014 . Invited expert evaluator. Ethics Panels. European Research Council, Brussels, 2012, 2013, 2014, 2015. Invited expert evaluator, Italian League Against Epilepsy research projects, March 2011, March 2012 Invited expert reviewer. DRUID FP7 project. DG Tren, EU Commission 2009- 2012. Invited expert reviewer. FP7 Ethical research lessons learnt, DG Research, EU Commission, Oct Dec 2010 Invited expert evaluator, Personalised medicines: Investigator-driven clinical trials on off-patent medicines for children. FP7-HEALTH-2011, Jan 2011 Invited expert evaluator. EUROCORES. European Science Foundation. Strasbourg France. 28-30 April 2010.
JOURNAL REVIEWER The Lancet Epilepsia, official peer-reviewed journal of the International League Against Epilepsy. Journal of Pharmacy and Pharmacology Journal of Biopharmaceutics & Drug Disposition Journal of Pediatric Neurology Maltese Medical Journal Journal of Malta College of Family Medicine British Medical Journal BMJ BMC Pharmacology and Toxicology British Journal of Clinical Pharmacology Current Psychiatry Reviews . Internet Journal Of Medical Education International Journal of Pharmacy and Pharmaceutical Sciences
COMMITTEE AND PANEL APPOINTMENTS
UNIVERSITY COMMITTEES Member, Doctoral School Committee, University of Medicine and Surgery, 2018- Chair, Presidency- Faculty Working Group, Faculty of Medicine and Surgery, University of Malta, 2014 - 2017 Member, Faculty Doctoral Committee, Faculty of Medicine and Surgery, University of Malta, 2014 - 2017 Member, Admissions Committee, Faculty of Medicine and Surgery, 2013- 2014 Member, Bioethics Research Programme, Faculty of Medicine and Surgery, University of Malta,
22/12/2020 European Medicine Agency Page 19/20 2010 - 2017 Member, EDRF, Tender Adjudication panels, 2010 Member, Gender Issues Committee, University of Malta, 2002-2003; 2008- to date Member, Visiting Staff Conjoint Council and Senate Committee, 2006-2008 Member, Curriculum Committee, Faculty of Medicine and Surgery, 1999-2009 Chairperson, Gender Issues Committee, University of Malta, 1999-2001 Member, Main Library Committee, University of Malta, 1998-2008 Member, Chaplaincy Team, University of Malta, 1998-2001 Member, Faculty Board, Faculty of Medicine and Surgery, 1997- to date Member, Faculty Board, Faculty of Dental Surgery, 1997-2006 Member, Library Sub-Committee, Faculty of Medicine and Surgery, 1997-2005 Member, Ethics Committee, Faculty of Medicine and Surgery 1997-1998; 2003- 2012.
National Contact Point and Member of the Committee of Scientific Officers, COST, Co-operation in Science and Technology, European Commission, 2010 - to date
CONTRIBUTION TO SOCIETY OF LOCAL AND/OR NATIONAL IMPORTANCE: NATIONAL COMMITTEES AND COMMISSIONS Board member, Centre for Freedom from Addiction, President's Foundation for the Wellbeing of Society, 2014 - to date Board member, Fund for Voluntary Organisations, Malta Community Chest Fund, 2014 - 2019 Scientific Expert, National Anti Doping Organisation (NADO), 2014 to date Board Member, New Hope Services for Drug Rehabilitation, Caritas Malta, 2015 to date Invited Participant, Focus Group on medicine accessibility in cross border health. Malta EU Presidency Feb 2016 Invited participant, Women in Malta Photo Exhibition, Valletta 8 -24 March 2015 Mentor, National Commission for the Promotion of Equality, 2014 - 2015 Expert evaluator, Malta European Union Projects Agency, 2014 - 2015 Board Director, Malta Council for Science and Technology, 2013 - 2017 Board Member, Malta Government Scholarship Scheme (MGSS), 2013 - 2017 Member, National Anti Doping Sports Advisory Board, 2003-2004 Adviser, Medicines Regulatory Authority, 2002- to date Member, European Union Programmes Unit Board, February 2001-November 2002 Member, Adjudicating Board, BPC award to Journalists Malta, 2001, 2002 Member, Borderline Substances Committee, Malta Standards Authority, 2001-2007 Member, Malta Council of Science and Technology Board, February 2001-March 2005 Member, Public Service Commission, Malta, 2000-2009 Member, Bioethics Consultative Committee, Ministry of Health, Malta, 2000-2002 Member, Medical Commission, Malta Football Association, 1999-to date Member, Medical Commission, Malta Sports Council, 1999-2004 Secretary, Epilepsy Society of Malta, 1997-to date Founder Member and adviser, Caritas Malta Epilepsy Association, 1995-to date
22/12/2020 European Medicine Agency Page 20/20